https://www.fool.com/investing/2021/04/21/will-regenerons-covid-cocktail-win-be-short-lived/
The biotech's antibody therapy continues to show promise. But there's considerable uncertainty about its long-term prospects.
regeneroncovidcocktailwinshort
https://www.theatlantic.com/sponsored/regeneron-2021/the-future-depends-on-young-scientists/3657/
The coming decades promise a cascade of converging crises. How do we educate the future scientific workforce so it's ready to address them? We asked finalists...
the futuredependsyoungscientistssponsor
https://www.regeneron.com/contact
Contact Regeneron for information about corporate communications, media relations, investor relations or business development.
contact for moreinformationregeneron
https://sefi.org/two-indiana-students-win-awards-at-the-2022-regeneron-international-science-and-engineering-fair-in-atlanta/
The Science Education Foundation of Indiana (SEFI) funded a delegation of 30 individuals, including 25 student finalists and 5 chaperones, to attend the 2022...
win awardstwoindianastudentsregeneron
https://www.roche.com/investors/updates/inv-update-2021-01-26
Dear Investor, Please find attached a press release from our partner Regeneron: ...
regeneronreportspositiveinterimdata
https://www.regeneron.com/stories/volunteer-project-leaders-share
Doing well by doing good drives Regeneron. Hear from our Day for Doing Good (D4DG) leaders on why they volunteer for causes they care about.
doing goodmattersusregeneron
https://www.fool.com/investing/general/2017/03/30/regenerons-game-changing-new-eczema-drug-could-be.aspx
The FDA has approved Dupixent for moderate to severe eczema, making it the first non-topical drug to win regulatory support in the indication.
game changingregeneronneweczemadrug
https://www.regeneron.com/stories/science-with-purpose-responsibility-report
Read the 2024 Responsibility Report highlighting the focus within key areas that captures the work, values, and progress that drives Regeneron®.
our valuesin actionsciencepurposeregeneron
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-strengthens-strategic-immuno-oncology-collaboration-with-regeneron-301078268.html
/PRNewswire/ -- ISA Pharmaceuticals B.V., a private clinical-stage immunotherapy company, today announced plans to initiate a potentially pivotal clinical...
isapharmaceuticalsstrategicimmunooncology
https://giantsight.com/stocks/75886F107
Investor activity analysis: REGENERON PHARMACEUTICALS (REGN) - held by 9 investors. Track latest portfolio changes
regeneron pharmaceuticalsregn
https://www.pharmavoice.com/news/regeneron-oncology-cancer-libtayo-bispecific-antibody-keytruda-opdualag/729415/
Although Regeneron has been playing catch-up in the oncology field for years, a pipeline built on next-wave promises could push the boundaries.
the long haulregenerontakesapproachoncology
https://www.biopharmadive.com/news/regeneron-decibel-ear-gene-therapy-acquire-deal/690376/
Third Rock-founded Decibel, which has shed much of its value since a 2021 IPO, expected to run out of money within a year.
genetic medicinebiopharma diveregeneronupsinvestment
https://www.biospace.com/regeneron-presentations-at-ash-highlight-expanding-clinical-research-in-blood-cancers-and-disorders
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that new and updated data from its diverse hematology program in blood cancers and disorders...
clinical researchregeneronpresentationsashhighlight
https://www.regeneron.com/science/technology/antibodies
Explore Regeneron's groundbreaking research and advancements in antibody medicine.
regeneronantibodyresearchmedicines
https://www.biospace.com/business/regeneron-sues-sandoz-in-federal-court-to-block-eylea-biosimilar
In its legal complaint, filed in the District Court for New Jersey, Regeneron alleges that Sandoz failed to provide it with relevant information required under...
federal courtregeneronsuessandozblock
https://www.fool.com/investing/2019/06/10/heres-why-regeneron-pharmaceuticals-tumbled-12-in.aspx
Sales growth is slowing, and there's an issue with one of the biotech's pipeline drugs.
regeneron pharmaceuticalstumbledmay
https://www.regeneron.com/responsibility/fueling-stem-innovators
Explore our STEM pre-college and high-school competitions offering awards, prizes and scholarships for students and our STEM mentorship & training programs.
stemstudentprogramspartnershipsregeneron
https://stockhouse.com/opinion/independent-reports/2019/09/24/regeneron-reports-positive-phase-3-dupixent-data-gains-eu-approval
Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with...
regeneronreportspositivephasedupixent
https://www.benzinga.com/general/biotech/22/04/26684117/the-daily-biotech-pulse-regeneron-acquires-checkmate-pharma-modernas-bivalent-booster-covid-19-va
Here's a roundup of top developments in the biotech space over the last 24 hours.
the dailybiotechpulseregeneronacquires
https://www.regeneron.com/science/technology
Explore Regeneron’s innovative technologies powering our antibody discovery and development and new therapeutic methods like gene editing and cell therapy.
regenerontechnologies